Nezha ipoNezha plans to have an IPO in 2021 and plans to launch its third mass-produced car, Nezha V, in the third quarter of this year. According to public information, Nezha Car is one of the car brands under Zhejiang Hezhong New Energy Vehicle Co., Ltd., established in October 2014 with a registered capital of 1.393 billion yuan. Nezha has completed several rounds of financing, with a total amount of more than 20 billion yuan. It was revealed that Nezha Car had started preparations for an IPO in Hong Kong, and the cornerstone investment amount signed at present had exceeded 2 billion yuan. In addition, Nezha's delivery volume has increased significantly this year, with an estimated annual delivery volume of more than 60,000 vehicles. However, there was no information on the exact timeline and size of the IPO.
What are the gmp certification of the medicine cooler?There were many requirements involved in the certification of the drug cooler, which was also related to the drug cooler.
1. ** Automatic monitoring and recording of temperature and humidity **
- The enterprise should be equipped with an automatic temperature and humidity monitoring system to continuously, automatically monitor and record the temperature and humidity of the warehouse environment 24 hours a day. The system was composed of a management host, a measuring point terminal, and operating software. The main server could display the temperature and humidity of each monitoring point in real time. The data of the measuring point is updated at least once every 5 seconds, and the actual temperature and humidity values are automatically recorded at least once every 30 minutes. The accuracy of the temperature and humidity data measured by the system shall meet the requirements of temperature +0.5 ° C and relative humidity +3%. The monitoring data recorded by the system must be true, complete, accurate, and effective. The data of each measuring point shall be automatically transmitted to the management host through the network, and the data shall be saved in a reliable way to prevent users from changing it themselves.
2. ** Setting of temperature and humidity monitoring equipment **
- Each independent medicine warehouse (or warehouse) and storage facility should be equipped with temperature and humidity monitoring equipment for automatic monitoring and data collection of environmental temperature and humidity. Generally, there should be no less than one monitoring equipment for every 300 square meters of flat warehouses, and at least one monitoring equipment should be added for every additional 300 square meters. The automatic three-dimensional warehouse should be evenly distributed in the upper, middle and lower positions of the warehouse, and the number should be no less than nine. The setting of monitoring equipment should take into account the structure of the warehouse, the air outlet, the location of the doors and windows, and the drug storage area to prevent the monitoring data from being affected.
3. ** Controlling and recording of temperature and humidity **
- The warehouse should be equipped with equipment that can effectively regulate the temperature and humidity. The automatic temperature and humidity monitoring system should have the function of controlling the node command output. When the average value of temperature and humidity in the warehouse is close to the specified upper and lower limit critical value or exceeds the specified range, the system shall be able to realize the sound and light alarm function on the spot and at the designated place. The warehouse management personnel should adjust the temperature and humidity in time according to the system prompt, and the adjustment process should be recorded.
4. ** Power supply interruption **
- The system should be able to continue working in the case of power interruption, normally monitor and record the temperature and humidity of each measuring point, and give an audible and visual alarm at the designated point and communication prompt to the designated personnel when the power is cut off.
5. ** In terms of calibrationing or accuracy verification **
- The temperature and humidity monitoring and control equipment shall be regularly subjected to annual calibrations or accuracy checks and records. The records of temperature and humidity monitoring, control and equipment calibrations shall be kept for at least 3 years.
6. ** System Supervision **
- The system should be able to accept the real-time supervision of the drug administration.
<a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Pangu intelligent ipoPangu Intelligent was listed for an initial public offering on the Growth Enterprise Market of the SZX on July 14,2023. 37,150,000 shares were publicly issued, accounting for 25.00% of the total share capital after the issue. The issue price was 37.96 yuan/share. The issued shares were all new shares, and the shareholders of the company did not carry out public offering of shares. The sponsor was Guojin Security Co., Ltd., and the sponsor representatives were Li Huiming and Yu Le. The total amount of funds raised by the company was 1,410,214,000 yuan. After deducting the issuing expenses, the actual net amount of funds raised was 1,287,700,600 yuan. The final net amount of funds raised was 537,700,600 yuan more than the original plan.(The original plan was to raise 750,000,000 yuan for the second phase expansion project of Pangu lubrication-hydraulic system, Pangu Intelligent (Shanghai) Technology R & D Center project, replenishment of working capital, etc.). The total issuing cost was 122,513,400 yuan, of which Guojin Security Co., Ltd. received 98,343,000 yuan in sponsorship and underwriting fees.
'The Myth of True Love in the Pangu Progenitor Universe' is equally wonderful. Please click to read it!
What are the requirements of the gmp specifications for pharmacy retail enterprisesThe following requirements are set in the drug store retail enterprise's GPS:
1. ** In terms of operating according to laws and regulations **
- They shall engage in business activities in accordance with the business methods and business scope approved by law.
- The main person-in-charge of the enterprise is responsible for the quality of the drugs sold by the enterprise.
- If the drug trading license is within the period of validity, the drug trading enterprise license, business license, and practice certificate that meets the requirements of the practitioners shall be hung in a prominent position in the business hall.
2. ** Quality Management Organization and Personnel **
- A quality management organization or full-time quality management personnel shall be set up to be responsible for the quality management of the enterprise, including the implementation of national laws, regulations and administrative rules on drug quality management, such as drafting the drug quality management system of the enterprise, guiding and supervising the implementation of the system; responsible for the quality review of the first-run enterprises and first-run varieties; establishing the quality files of the drugs sold by the enterprise, including the quality standards; To be responsible for inquiring about the quality of drugs and investigating, handling and reporting on drug quality accidents or complaints; to be responsible for the management of drug acceptance; to be responsible for guiding and supervising the quality work in the storage, maintenance and transportation of drugs; to be responsible for the review of unqualified drugs and supervising the handling process of unqualified drugs; to be responsible for collecting and analyzing drug quality information; to assist in the education or training of drug quality management for the enterprise employees.
- The person in charge of quality management in large and medium-sized enterprises should have the technical title of pharmacist (including pharmacist and traditional Chinese medicine master) or above; the person in charge of quality management in small enterprises should have the technical title of pharmacist (including pharmacist and traditional Chinese medicine master) or above.
3. ** Quality Management System **
- It is necessary to formulate the quality responsibilities of relevant businesses and management posts; regulations on the purchase, acceptance, storage, display, and maintenance of drugs; regulations on the review of first-run enterprises and first-run varieties; regulations on drug sales and prescription management; regulations on the management of disassembled drugs; regulations on the purchase, storage, safekeeping, and sales of specially-controlled drugs; regulations on the handling and reporting of quality accidents; regulations on the management of quality information; regulations on the reporting of adverse drug reactions; and various hygiene management systems; The management regulations on the health status of the personnel, the management regulations on the service quality, and the quality management system that meets the regulations on the purchase, sales, and storage of the Chinese herbal pieces should be established for the enterprises that operate the Chinese herbal pieces.
- All management systems should be checked and assessed regularly, and records should be established.
4. ** Purchasing and management **
- The Purchasing Department should carefully screen the suppliers and commodities, and the Quality Management Department should carefully do a good job in the first business enterprise and the first business variety review. Only the qualified suppliers that have been approved by the Quality Management Department of the enterprise are qualified to supply the enterprise. They are not allowed to purchase drugs from the unapproved suppliers. Only the qualified products that have been approved by the Quality Management Department can be purchased by the purchasing staff. If they have not passed the review, the purchasing staff is not allowed to purchase without authorization.
- Sell and store drugs at the address approved by the drug administration department in accordance with the business method and business scope stated in the drug business license, operate in good faith according to laws and regulations, and establish a drug tracing system to ensure that the entire process of drug distribution can be traced back and not beyond the scope of business.
- Pharmacies that deal in anesthetics, Class I psychotropics, and precursor chemicals should be inspected twice or more each year, one of which should be the inspection of drug compliance with GPS; It operates chilled and frozen drugs, second-class psychiatric drugs, medical toxic drugs companies, and pharmaceutical third-party logistics companies (Including the third-party logistics management of drugs) and their business sites should be inspected once or more every year, and at least once in three years should be the inspection of drug GPS compliance. The inspection should cover no less than one-third of the relevant business sites or at least five storage and distribution sites. The drug supervision and administration department will also select a certain proportion of enterprises to carry out drug GPS compliance inspection every year. In addition, all drug trading enterprises in the administrative region will be inspected within three years.
<a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Nezha Car's ipoNezha Car had already started preparations for its Hong Kong IPO. According to insiders, Nezha Car had already started preparations for an IPO in Hong Kong in the fourth quarter of 2023, and the cornerstone investment that had been signed had exceeded 2 billion yuan. In addition, Nezha L, a new large five-seater SUV under Nezha, would also be officially launched in April. However, information about the specific progress of the IPO, investors, and the purpose of the financing was not disclosed. Therefore, it can be concluded that Nezha has already started preparations for the Hong Kong IPO, but the specific details have not yet been made public.
Guangyun Technology's ipoGuangyun Technology was listed on the Science and Technology Board of the Shanghai Exchange on April 29,2020. The issue price was 10.80 yuan/share, and the number of publicly issued shares was 40.1 million shares. The sponsor (lead underwriter) was China International Finance Corporation. The total amount of funds raised from the initial public offering of Guangyun Technology was 433,080,000 yuan. After deducting the issuing expenses, the net amount of funds raised was 369,548,300 yuan. The total cost of its initial public offering was 63,531,700 yuan, and the sponsorship and underwriting fee received by China International Capital Corporation was 45,600,000 yuan.
The novel "The Clouds Come and Go in the Morning" is equally wonderful. Everyone is welcome to click and read it!
If the feather minister ipo progressRuoyuchen was approved by the 18th session of the Board of Directors of the China Merchants Exchange and Clearing Committee on July 3, 2020. On December 1,2024, Ruoyu Chen announced that the number of shares repurchased by the company was 6,012,800 shares, accounting for 3.54% of the total share capital before the deregistration. After the completion of the deregistration, the total share capital of the company was changed from 170 million shares to 164 million shares. As of November 29,2024, the matter of canceling the shares repurchased had been completed at the China Security Depository and Clearing Corporation Limited's Shen Zhen Branch.
The original novel of " The Shadow of Beacon Burning Plum Fragrance " was " The Hitman's Diary of the Pseudo Song Dynasty." The original plot was equally exciting. You can click on the link below to read the original novel.
Ruo Yuchen's ipoIf Yu Chen's initial public offering was approved on July 3,2020, it was planned to issue no more than 30.43 million new shares on the small and medium-sized board of the SZEQ, which was no less than 25% of the company's total share capital after the issue. It was planned to raise 717 million yuan to be used for various projects such as the "New Brand Incubation Platform Construction Project" and to supplement working capital. The sponsor was China International Capital Corporation. This was not the first time that Ruo Yuchen had sought an A-share listing. As early as December 2015, it had been listed on the New Third Board. In August 2017, it entered the termination of the review after submitting the first offer to the China Security and Exchange Commission.
The original novel of " The Shadow of Beacon Burning Plum Fragrance " was " The Hitman's Diary of the Pseudo Song Dynasty." The original plot was equally exciting. You can click on the link below to read the original novel.
Xingchen Technology's ipoXingchen Technology was listed on the Growth Enterprise Market of the Shen Zhen stock exchange on March 28, 2024, with the stock code of 301536. The number of publicly issued shares was about 42.1126 million shares, the issuing price was 16.16 yuan/share, and the total amount of funds raised was estimated to be about 681 million yuan.
"The Alliance of Stars: A Symphony of Fate and Power" is equally exciting. Everyone is welcome to click and read it!
Bright moon lenses ipo revealedMingyue lenses 'IPO revealed many situations in the glasses industry. The first was the industry's "profiteering" phenomenon. From the Mingyue lens's offering document, the cost of lenses was relatively low. For example, the average annual cost of a lens was 6.77 yuan, but the price of selling to consumers could climb to a few hundred yuan or even 2000 yuan, and the gross profit margin of e-commerce sales was as high as 91.7%. At the same time, Mingyue lenses 'IPO also exposed some of its own problems, such as the decline in the production capacity of each period of lenses year by year, the number of dealers decreasing year by year, and there were doubts about the dealers, including the low percentage of actual sales volume and purchase volume of dealers, the mismatching of business scale and sales contribution of some major dealers, and the situation of seemingly determining revenue in advance. Mingyue lenses did not respond to this. In addition, although there was an inventory value of more than 100 million yuan and it was difficult to get back the goods sold, Mingyue lenses still needed to raise funds to expand production.